Kala BioKALA

13F holders, Q3 2025 (September 30)
22holders −6
5new positions
10sold out
$1.54avg. 13F price*

At the end of Q3 2025, 22 institutions reported holding Kala Bio Inc. (KALA) in their 13F filings, down 6 from Q2 2025. 5 opened new positions and 10 sold out. The largest holders were Baker Bros. Advisors LP ($1.5M), Woodline Partners LP ($379K) and Vanguard Group Inc. ($323K).

Company
Kala Bio Inc.
CUSIP
483119202
Latest filing quarter
Q1 2026

History

Number of 13F holders

010203040 Q1 2024: 28Q1 2024Q2 2024: 28Q2 2024Q3 2024: 26Q3 2024Q4 2024: 32Q4 2024Q1 2025: 27Q1 2025Q2 2025: 28Q2 2025Q3 2025: 22Q3 2025Q4 2025: 29Q4 2025Q1 2026: 27Q1 2026

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions5$81K
Exits10$8.2M

All 13F filers, Q2 2025 → Q3 2025: 111,955 shares bought and 2,003,850 shares sold, net −1,891,895 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 22 holders

Baker Bros. Advisors LP 0.01% Reduce -18.0% 985,093 $1.5M
Woodline Partners LP 0.00% Reduce -17.6% 247,466 $379K
Vanguard Group Inc. 0.00% Add +23.7% 210,826 $323K
ADAR1 Capital Management, LLC 0.02% Reduce -5.2% 141,995 $217K
Geode Capital Management, LLC 0.00% Add +20.5% 67,912 $104K
State Street Corp. 0.00% New 28,576 $44K
Marex Group Ltd 0.00% New 14,500 $35K
BlackRock, Inc. 0.00% Add +0.2% 21,407 $33K
Northern Trust Corp. 0.00% Add +10.8% 11,524 $18K
UBS Group AG 0.00% Add +23997.1% 8,193 $13K
Tower Research Capital LLC (TRC) 0.00% Add +344.1% 5,076 $8K
Morgan Stanley 0.00% Add +57.7% 1,533 $2K
Bank of America Corp. 0.00% Add +1454.1% 1,523 $2K
Covestor Ltd 0.00% Add +11.1% 1,264 $2K
Caitong International Asset Management Co., Ltd 0.00% New 736 $1K
Citigroup Inc. 0.00% New 721 $1K
MAI Capital Management 0.00% No change 300 $459
Steward Partners Investment Advisory, LLC 0.00% No change 120 $184
JPMorgan Chase & Co. 0.00% Reduce -78.5% 51 $78
PNC Financial Services Group, Inc. 0.00% New 46 $70
Legacy Wealth Managment, LLC 0.00% No change 25 $39
SBI Securities Co., Ltd. 0.00% No change 8 $12

"% of holder's portfolio" is KALA's weight in each manager's 13F, not the share of Kala Bio Inc. the manager owns.